A Phase II trial of PAN-301-1

Trial Profile

A Phase II trial of PAN-301-1

Planning
Phase of Trial: Phase II

Latest Information Update: 06 Feb 2018

At a glance

  • Drugs PAN 301 1 (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Feb 2018 New trial record
    • 01 Feb 2018 According to a Panacea Pharmaceuticals media release, the company anticipates initiating this trial in the second half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top